LEXETTE
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 25 Jan 2025)
What this means for you
Registered since 27 Aug 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88067259
- Registration number
- 5846852
- Mark type
- Stylized text
- Filed
- 06 Aug 2018
- Published for opposition
- 01 Jan 2019
- Registered
- 27 Aug 2019
- Attorney of record
- Melissa A. Nowak
Goods and services
- Class 005 — Pharmaceuticals: topical foam pharmaceutical products for treatment of steroid responsive dermatoses
Owner
- Mayne Pharma LLC, Greenville, NC, US
- Mayne Pharma LLC, Greenville, NC, US
- Mayne Pharma LLC, Greenville, NC, US
Prosecution history
- 25 Jan 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 25 Jan 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 25 Jan 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 05 Sept 2024 — TEAS SECTION 8 & 15 RECEIVED
- 27 Aug 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 27 Aug 2019 — REGISTERED-PRINCIPAL REGISTER
- 24 Jul 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 23 Jul 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Jun 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 23 May 2019 — USE AMENDMENT FILED
- 23 May 2019 — TEAS STATEMENT OF USE RECEIVED
- 20 Mar 2019 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 20 Mar 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 28 Feb 2019 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 26 Feb 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT